Cardiology Devices - Romania | Statista Market Forecast

The projected revenue for the Cardiology Devices market market in Romania is estimated to reach US$314.10m in 2025.
It is expected to experience an annual growth rate of 5.54% from 2025 to 2029, resulting in a market volume of US$389.65m by 2029.
When compared globally, the United States is anticipated to generate the highest revenue of US$27.42bn in 2025.
Romania is experiencing a growing demand for advanced cardiology devices, driven by an aging population and increased awareness of cardiovascular health.

Definition:
The Cardiology Devices market includes diagnostic, monitoring, and surgical devices that are used to treat heart diseases and heart-related problems.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Medtronic, Abbott Laboratories, Boston Scientific, Edwards Lifesciences.
Further information on the key players can be found in the Market Shares boxes.

Cardiology diagnostic & monitoring devices
Cardiology surgical devices
Implants such as pacemakers

Cardiology drugs
Cardiology supplements

Medical Devices: market data & analysis

The Cardiology Devices market in Romania is experiencing steady growth due to a combination of customer preferences, market trends, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Cardiology Devices market in Romania are influenced by several factors. Firstly, there is a growing demand for advanced and innovative medical devices that can provide accurate diagnoses and effective treatments for cardiovascular diseases. Patients and healthcare professionals alike are seeking devices that can improve patient outcomes and quality of life. Additionally, there is a preference for minimally invasive procedures and devices that can reduce the need for invasive surgeries, leading to shorter recovery times and lower healthcare costs. Trends in the market are also contributing to its development in Romania. One notable trend is the increasing adoption of digital health technologies, such as wearable devices and remote monitoring systems. These technologies allow for real-time monitoring of patients' cardiovascular health, enabling early detection of potential issues and timely interventions. Another trend is the integration of artificial intelligence and machine learning algorithms into cardiology devices, which can enhance diagnostic accuracy and treatment planning. Local special circumstances in Romania are also playing a role in the development of the Cardiology Devices market. The country has a high prevalence of cardiovascular diseases, including hypertension, ischemic heart disease, and heart failure. This creates a significant demand for cardiology devices and related treatments. Additionally, Romania has been investing in improving its healthcare infrastructure and expanding access to healthcare services, which further drives the demand for cardiology devices. Underlying macroeconomic factors are also contributing to the growth of the Cardiology Devices market in Romania. The country has been experiencing steady economic growth, which has led to increased healthcare spending. As the economy continues to develop, more resources are being allocated to the healthcare sector, including investments in medical devices and technologies. Furthermore, Romania is part of the European Union, which provides access to a larger market and facilitates trade and regulatory harmonization. In conclusion, the Cardiology Devices market in Romania is developing due to customer preferences for advanced and minimally invasive devices, market trends such as digital health technologies and artificial intelligence, local special circumstances including a high prevalence of cardiovascular diseases and investments in healthcare infrastructure, and underlying macroeconomic factors such as economic growth and EU membership. These factors are driving the demand for cardiology devices and creating opportunities for market growth in Romania.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.

Cardiology Devices - Romania

Revenue

Key Players

Analyst Opinion

Global Comparison

Methodology

Health

Access more Market Insights on Health topics with our featured report

Key Market Indicators

Explore more high-quality data on related topic

Medical technology industry - statistics & facts

Contact